XERS earnings: a positive outcome, +13.8%

On May 9, 2023, Xeris Biopharma Holdings, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.8% in the window around the event. It had already run +27.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.